# DEPAKOTE ER
> **NDA020782** · New Drug Application · Sponsor: ABBOTT · Approved 2002-12-20
## Drug
- **FDA Application Number:** NDA020782
- **Application type:** New Drug Application
- **Brand name:** DEPAKOTE ER
- **Generic name:** Divalproex Sodium
- **Active ingredients:** DIVALPROEX SODIUM
- **Dosage form:** Tablet, Extended Release
- **Route:** Oral
- **Marketing status:** Prescription
- **Sponsor:** ABBOTT
- **First approval:** 2002-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020782)
---
*AI Analytics · CC0 1.0*